Building the Bioworkforce of the Future
Bioengineering, Biomanufacturing, Biopharmaceutical, Synthetic Biology, Workforce

In September 2022, President Biden signed Executive Order (E.O.) 14081 on Advancing Biotechnology and Biomanufacturing Innovation for a Sustainable, Safe, and Secure American Bioeconomy. The E.O. directs the United States Government to expand training and education opportunities for all Americans in biotechnology and biomanufacturing. Specifically...

PCAST_Biomanufacturing-Report_Dec2022_Cover
Bioengineering, Biofabrication, Biomanufacturing, Biopharmaceutical, COVID-19, Synthetic Biology, Workforce

Advances in biotechnology over the past decade have led to an explosion of innovative new products that touch many aspects of American life, from novel RNA vaccines and cell-based medicines, to engineered meats and plants, to fuels and chemicals made from renewable resources, and much more. Science and engineering continue to unveil new ways of...

NIIMBL Annual Report 2020-21 Cover
Biopharmaceutical, COVID-19, Workforce

NIIMBL, the Manufacturing USA institute for biopharmaceutical manufacturing innovation, has released its 2020–2021 Annual Report covering the period from March 2020 through February 2021. Amid the global COVID-19 pandemic, NIIMBL swiftly backed innovative projects that supported the U.S. response to the COVID-19 pandemic. Its community came...

Thumbnail
Biomanufacturing, Biopharmaceutical, Education, Workforce

The biopharmaceutical industry makes a substantial impact on the health, well-being, and economic prosperity of the nation. The industry develops and manufactures life-changing therapies for patients and contributes significantly to the U.S. economy. Currently, the industry accounts for nearly $800B of total economic activity per year and directly...